Perseus Proteomics Inc. provided earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects net sales of JPY 100 million, operating loss of JPY 991 million, loss of JPY 1,185 million and basic loss per share of JPY 100.84.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
329 JPY | +2.49% | +7.17% | -46.76% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.76% | 25.39M | |
+0.47% | 91.26B | |
-2.37% | 38.17B | |
+71.42% | 26.74B | |
-12.31% | 15.93B | |
-4.54% | 13.37B | |
-10.83% | 11.77B | |
+180.20% | 10.92B | |
-48.60% | 10.27B | |
+1.42% | 8.69B |
- Stock Market
- Equities
- 4882 Stock
- News Perseus Proteomics Inc.
- Perseus Proteomics Inc. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024